Literature DB >> 11910610

The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36.

H P Schneider1, L A Heinemann, H P Rosemeier, P Potthoff, H M Behre.   

Abstract

OBJECTIVE: To evaluate further the Menopause Rating Scale (MRS) for scoring menopausal symptoms by comparison with other instruments relevant for women in their menopausal transition: the Kupperman index and the quality-of-life scale SF-36.
METHOD: A population sample of 306 women, who had been randomly selected from an initially representative survey of German women (aged 40-60), completed three questionnaires in 1997: the Menopause Rating Scale (MRS), the Kupperman index and the short form-36 (SF-36).
RESULTS: A comparison of the MRS with the Kupperman index produced a high correlation of raw scores (r = 0.91). The highest association of scores (80%) was found in the highest quartile of the MRS. The terms 'mild', 'moderate' and 'severe', relating to the degree of severity of menopausal symptoms, reflect different contents and spread in each scale, i.e. are not directly comparable. There is a strikingly good association between the subscales of the SF-36 and the MRS. The MRS correlates best with those dimensions of the SF-36 that are highly relevant for women in the menopausal transition. For this reason, the MRS can be utilized as an age- and condition-specific quality-of-life instrument.
CONCLUSIONS: The Menopause Rating Scale is a valuable modern tool for the assessment of menopausal complaints. It combines in practice excellent applicability and good reliability, and there are normal values for the population available. The MRS could serve as an adequate diagnostic instrument for menopausal quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 11910610     DOI: 10.3109/13697130009167599

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  25 in total

1.  Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.

Authors:  Andrej Rasch; Jan-Marc Hodek; Claus Runge; Wolfgang Greiner
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients.

Authors:  Karsten Münstedt; Benjamin Voss; Uwe Kullmer; Ursula Schneider; Jutta Hübner
Journal:  Mol Clin Oncol       Date:  2015-05-04

3.  The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.

Authors:  Carmel Pezaro; Paul James; Joanne McKinley; Mary Shanahan; Mary-Anne Young; Gillian Mitchell
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.

Authors:  Amy D DiVasta; Henry A Feldman; Jenny Sadler Gallagher; Natalie A Stokes; Marc R Laufer; Mark D Hornstein; Catherine M Gordon
Journal:  Obstet Gynecol       Date:  2015-09       Impact factor: 7.661

Review 5.  Literature review of instruments to assess health-related quality of life during and after menopause.

Authors:  Y F Zöllner; C Acquadro; M Schaefer
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

6.  Citalopram improves vasomotor syndrome and urogenital syndrome of menopause in Mexican women: a randomized clinical trial.

Authors:  Patricia Loranca-Moreno; Juan Moises Ocampo-Godínez; Alan Rios-Espinosa; Magdalena Cruz-Luna; Carolina Garmendia-Gallardo; Merle Yasmin Hernández-Castañón; Verónica Yazmin Hernández-Hernández; Paula Mariana Sánchez-Tinoco; Alma Bajonero-Domínguez; Jael Adrián Vergara Lope-Núñez; Marco Antonio Álvarez-Pérez; José Luis González-Quiroz
Journal:  Arch Gynecol Obstet       Date:  2022-08-23       Impact factor: 2.493

7.  Suan zao ren tang as an original treatment for sleep difficulty in climacteric women: a prospective clinical observation.

Authors:  Chia-Hao Yeh; Christof K Arnold; Yen-Hui Chen; Jung-Nein Lai
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-10       Impact factor: 2.629

Review 8.  Assessment of the climacteric syndrome: a narrative review.

Authors:  Marina Sourouni; Martina Zangger; Livia Honermann; Dolores Foth; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2021-07-06       Impact factor: 2.344

9.  Dose-Dependent Effects of the Cimicifuga racemosa Extract Ze 450 in the Treatment of Climacteric Complaints: A Randomized, Placebo-Controlled Study.

Authors:  Ruediger Schellenberg; Reinhard Saller; Lorenzo Hess; Jörg Melzer; Christian Zimmermann; Juergen Drewe; Catherine Zahner
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-23       Impact factor: 2.629

10.  Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women.

Authors:  Minfang Tao; Hongfang Shao; Changbing Li; Yincheng Teng
Journal:  Patient Prefer Adherence       Date:  2013-03-20       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.